Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

Breakthrough Organ Preservation Technology: Achieving Long-Term and Safe Preservation of Cells and Organs

Breaking the Cryopreservation Bottleneck: New Pretreatment Technique Boosts NK Cell Recovery Rate to 90%–100% After Thawing

Scientists Achieve Functional "Revival" of Mouse Brain Tissue After Rewarming from -196°C Freezing First Successful Revival of Frozen Brain! Mouse brain tissue regains memory function after being frozen at -196°C and rewarmed

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

2026/09/09

This head‑to‑head comparative study, backed by solid and transparent data, unequivocally demonstrates that China‑developed cryoprotectants already possess significant international competitiveness in core performance. This not only reflects Yinfeng's technological prowess but also serves as a compelling testament to China's cryobiomedicine field transitioning from "following" to "running alongside" global leaders—earning international discourse power through scientific evidence.

Breakthrough Organ Preservation Technology: Achieving Long-Term and Safe Preservation of Cells and Organs

2026/05/18

Beyond organ transplantation, this non-toxic low-temperature preservation framework can be extended to long-term storage of stem cells, reproductive cells, and germplasm resources of endangered species, providing a universal technological foundation for biobanks, regenerative medicine, and other fields.

Breaking the Cryopreservation Bottleneck: New Pretreatment Technique Boosts NK Cell Recovery Rate to 90%–100% After Thawing

2026/04/29

The clinical value of this approach lies in its extremely simple operation. It requires no specialized cryopreservation solutions or complex equipment, using only GMP‑grade compliant cytokines that can be removed by routine washing after pretreatment, posing no additional safety risks to patients and enabling rapid integration into existing cell production and cryopreservation workflows. As the large‑scale manufacturing of NK cells derived from umbilical cord blood and iPSCs becomes increasingly mature, combining this cryopreservation technology holds the potential to significantly reduce cell therapy costs and improve accessibility, opening new avenues for immunotherapy in hematological malignancies and solid tumors.

Scientists Achieve Functional "Revival" of Mouse Brain Tissue After Rewarming from -196°C Freezing First Successful Revival of Frozen Brain! Mouse brain tissue regains memory function after being frozen at -196°C and rewarmed

2026/03/16

In science fiction, human cryopreservation and resuscitation are often regarded as a "time capsule" to the future. Now, this concept has achieved a milestone breakthrough in the laboratory—scientists have for the first time successfully cryopreserved adult mouse brain slices in liquid nitrogen at -196°C and restored multiple key neural functions, including learning and memory mechanisms, after rewarming. This achievement blazes a brand-new trail for basic neuroscience research and organ preservation technology.

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

2025/08/15

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

2025/07/03

On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.

2026-09-24

→

Light-Speed Thawing of Oocytes: 2D Material + Laser Raises Recovery Survival Rate to 81%

The path validated by this work is clear—allowing samples to rapidly and uniformly traverse the dangerous temperature zone from within to suppress devitrification, providing a useful approach for the cryopreservation of oocytes and even embryos and organs.

2026-09-24

→

Brain Implant Simultaneously Decodes Speech and Gestures, Giving Paralyzed Patients a New Way to “Speak”

However, initial validation has clearly shown that a single brain implant is enough to support multifunctional natural communication, paving the way for paralyzed patients to rebuild an expressive ability that combines speech and gesture.

2026-09-18

→

Nature Breakthrough: Growing a Human Brain in Mice!

The model is expected to accelerate research on diseases such as schizophrenia, epilepsy, autism, and cerebral palsy. However, the road to clinical application remains long, and the dual-track advancement of ethics and science will be key to ensuring steady and sustained progress in this field.

2026-09-18

→

Dressing Cells in an “Antifreeze Coat”: Chlorogenic Acid Can Improve the Cryosurvival Rate of Germline Stem Cells

However, this does not undermine the possibility that adding chlorogenic acid to cryopreservation solutions may be a new strategy for addressing cryopreservation damage in tissues and organs.

2026-09-09

→

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

2026-09-04

→

Science Fiction Becomes Reality? Scientists Precisely Locate Key Brain Circuit for Animal Hibernation, Marking a Major Step Forward in Artificial Hibernation Research

"This is still a very distant vision, but it is supported by very substantial funding." Although the road ahead is long, this study has laid a critical neuroscientific foundation for humanity to knock on the door of "artificial hibernation."

2026-09-04

→

Russian Scientists Extract "Brain-Repair Sponge" from Jellyfish, Bringing New Hope for Craniocerebral Injuries

Rodkin noted that this study also converts the environmental problem caused by overpopulation of the Azov Sea brown-rooted jellyfish into a source of modern biomedical materials, achieving "waste-to-wealth." Currently, further research is needed to bring this material to clinical application, but the scientific and technological foundations have been laid. This work was supported by the Russian Science Foundation and is expected to offer new therapeutic options for patients with craniocerebral injuries in the future.

2026-08-28

→

New Breakthrough in Oocyte Cryopreservation: Magnetically Controlled Hydrogel + Microfluidics Significantly Boosts Survival Rates

To address these challenges, a collaborative team led by Professor Chen Zhongrong from Anhui Medical University, Professor Zhao Gang from the University of Science and Technology of China, and Professor Cheng Yue from Anhui Medical University proposed an innovative solution—integrating a microfluidic chip with magnetically controlled hydrogel microencapsulation technology. This research has been published in the internationally renowned journal Biomaterials.

2026-08-28

→

Behind the $1.5 Billion Acquisition: Cryopreservation Enters the Era of Precision Engineering

The maturation of this paradigm not only facilitates scalable manufacturing of cell therapies but also establishes methodological foundations for scientific exploration of preserving more complex tissues and even whole organisms.

2026-08-14

→

Stem Cell-Derived Spinal Neurons Transplanted to Improve Respiratory Function in Rats, Providing New Evidence for Regenerative Therapy of Spinal Cord Injury

Before advancing toward clinical translation, follow-up work will need to validate efficacy in large animal models and assess therapeutic outcomes in late time windows—months to years post-injury—to reflect the most common clinical presentation timelines of patients seeking treatment.